John Maraganore News
Most Popular John Maraganore Story
Alnylam trial shows RNAi works in humans
Alnylam is offering up the first signs that RNAi therapy may work in humans. In a small Phase II trial, Alnylam's Read more...
Latest Headlines
- November 13, 2009
- September 15, 2008
- February 29, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
